Galectin Therapeutics SG&A Expense (TTM) Analysis

Galectin Therapeutics Inc (GALT)

2.74 +0.02 (+0.74%) USD | NASDAQ | May 31, 16:00

2.73 -0.01 (-0.36%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2002. Upgrade now.

Date	Value
March 31, 2024	5.993M
December 31, 2023	5.942M
September 30, 2023	6.235M
June 30, 2023	6.325M
March 31, 2023	6.281M
December 31, 2022	6.615M
September 30, 2022	6.558M
June 30, 2022	6.665M
March 31, 2022	6.82M
December 31, 2021	6.361M
September 30, 2021	6.253M
June 30, 2021	5.768M
March 31, 2021	5.446M
December 31, 2020	5.468M
September 30, 2020	5.399M
June 30, 2020	5.613M
March 31, 2020	5.69M
December 31, 2019	5.971M
September 30, 2019	6.372M
June 30, 2019	6.187M
March 31, 2019	6.972M
December 31, 2018	7.131M
September 30, 2018	6.709M
June 30, 2018	6.445M
March 31, 2018	5.232M

Date	Value
December 31, 2017	4.526M
September 30, 2017	4.321M
June 30, 2017	4.658M
March 31, 2017	4.893M
December 31, 2016	6.156M
September 30, 2016	6.759M
June 30, 2016	6.946M
March 31, 2016	7.698M
December 31, 2015	6.965M
September 30, 2015	6.85M
June 30, 2015	6.913M
March 31, 2015	6.637M
December 31, 2014	7.005M
September 30, 2014	6.76M
June 30, 2014	7.615M
March 31, 2014	7.032M
December 31, 2013	6.416M
September 30, 2013	6.387M
June 30, 2013	5.521M
March 31, 2013	5.776M
December 31, 2012	5.372M
September 30, 2012	6.502M
June 30, 2012	6.393M
March 31, 2012	6.64M
December 31, 2011	6.857M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

5.399M

Minimum

Sep 2020

6.82M

Maximum

Mar 2022

6.098M

Average

6.211M

Median

SG&A Expense (TTM) Benchmarks